Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer

BACKGROUND & OBJECTIVES: An association between over-expression of proto-oncogene Her-2/neu and resistance to tamoxifen in estrogen receptor (ER) positive, primary and metastatic breast cancer has been suggested. HR+/Her-2/neu+ patients have a poor response to endocrine therapy, making this grou...

詳細記述

保存先:
書誌詳細
主要な著者: James, Rani, Thriveni, K., Krishnamoorthy, Lakshmi, Deshmane, Vijayalaxmi, Bapsy, P.P., Ramaswamy, Girija
フォーマット: Artigo
言語:Inglês
出版事項: Medknow Publications 2011
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100149/
https://ncbi.nlm.nih.gov/pubmed/21321422
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料